Detalhe da pesquisa
1.
Deciphering radiological stable disease to immune checkpoint inhibitors.
Ann Oncol
; 33(8): 824-835, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533926
2.
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies.
Ann Oncol
; 32(6): 736-745, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667669
3.
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.
Ann Oncol
; 28(11): 2754-2760, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950297
4.
Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.
Ann Oncol
; 27(7): 1304-11, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059553
5.
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.
Ann Oncol
; 25(3): 663-668, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458473
6.
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
Eur J Cancer
; 114: 67-75, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31075726
7.
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders.
J Immunother Cancer
; 6(1): 159, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591082
8.
Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
Kidney Cancer
; 1(1): 49-56, 2017 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334004
9.
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
Bone Marrow Transplant
; 47(8): 1056-60, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22139066